Clinical Trial Update: Prophylaxis of Cytomegalovirus Infection With Adoptive Cell Inmunotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating adoptive cell immunotherapy as prophylaxis against cytomegalovirus infection is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• Adoptive Cell Immunotherapy

Snippet

Sponsor: Instituto de Investigación Marqués de Valdecilla | Conditions: CMV | Phase 2 | Status: RECRUITING